UBS analyst Dan Leonard lowered the firm’s price target on Fulgent Genetics (FLGT) to $20 from $27 and keeps a Neutral rating on the shares.
Fulgent Genetics ( NASDAQ:FLGT ) Full Year 2024 Results Key Financial Results Revenue: US$283.5m (down 2.0% from FY... EL MONTE, Calif., February 28, 2025--Fulgent Genetics, Inc. (NASDAQ ...
Piper Sandler analyst David Westenberg lowered the firm’s price target on Fulgent Genetics (FLGT) to $16 from $22 following quarterly results.
12d
TipRanks on MSNFulgent Genetics’ Earnings Call: Growth Amid ChallengesFulgent Genetics (($FLGT)) has held its Q4 earnings call. Read on for the main highlights of the call. Fulgent Genetics’ recent earnings call ...
Proficio Capital Partners LLC bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results